LTGO · Latigo Biotherapeutics, Inc. · Exempt Offerings
$15.26
+0.24 (+1.60%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26
165.33K
Avg daily vol (56 sessions)
349.92K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.